Sws Partners Guardant Health, Inc. Transaction History

Sws Partners

$310 Million
Q3 2024

A detailed history of Sws Partners transactions in Guardant Health, Inc. stock. As of the latest transaction made, Sws Partners holds 83,762 shares of GH stock, worth $2.64 Million. This represents 0.62% of its overall portfolio holdings.

Number of Shares

83,762

Previous 78,857 6.22%

Holding current value

$2.64 Million

Previous $2.28 Million 15.68%

% of portfolio

0.62%

Previous 0.69%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	BUY	$22.3 - $36.29 $109,381 - $178,002	4,905 Added 6.22%	83,762 $1.92 Million
Q2 2024 Jul 17, 2024	BUY	$16.07 - $31.84 $537,477 - $1.06 Million	33,446 Added 73.65%	78,857 $2.28 Million
Q1 2024 Apr 30, 2024	SELL	$17.13 - $26.91 $9,592 - $15,069	-560 Reduced 1.22%	45,411 $936,000
Q4 2023 Feb 13, 2024	SELL	$21.58 - $29.5 $15,623 - $21,358	-724 Reduced 1.55%	45,971 $1.24 Million
Q3 2023 Nov 09, 2023	BUY	$25.8 - $39.97 $68,705 - $106,440	2,663 Added 6.05%	46,695 $1.38 Million
Q2 2023 Aug 17, 2023	SELL	$20.94 - $38.01 $56,265 - $102,132	-2,687 Reduced 5.75%	44,032 $1.58 Million
Q2 2023 Aug 10, 2023	BUY	$20.94 - $38.01 $56,265 - $102,132	2,687 Added 6.1%	46,719 $1.67 Million
Q2 2023 Jul 26, 2023	SELL	$20.94 - $38.01 $9,632 - $17,484	-460 Reduced 1.03%	44,032 $1.58 Million
Q1 2023 May 09, 2023	BUY	$22.92 - $33.76 $77,721 - $114,480	3,391 Added 8.25%	44,492 $1.04 Million
Q4 2022 Jan 30, 2023	BUY	$25.44 - $59.78 $245,903 - $577,833	9,666 Added 30.75%	41,101 $1.12 Million
Q3 2022 Nov 09, 2022	BUY	$43.66 - $61.0 $260,650 - $364,170	5,970 Added 23.44%	31,435 $1.69 Million
Q2 2022 Jul 28, 2022	BUY	$28.82 - $77.35 $301,658 - $809,622	10,467 Added 69.79%	25,465 $1.03 Million
Q1 2022 May 05, 2022	BUY	$48.25 - $100.49 $723,653 - $1.51 Million	14,998 New	14,998 $995,000

Others Institutions Holding GH

# of Institutions

323

Shares Held

127M

Call Options Held

844K

Put Options Held

2.38M

View Full List

About Guardant Health, Inc.

Ticker GH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,220,000
Market Cap $3.23B
Description
Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...

More about GH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Sws Partners, based on Form 13F filings with the SEC.

News

Stay updated on Sws Partners with notifications on news.

Account